MAP® – Master Amino Acid Pattern®

Description

3 bottles of MAP® is a dietary protein substitute that provides the MAP Master Amino Acid Pattern® (U.S. Patent No. 5,132,113) a unique pattern of essential amino acids in a highly purified, free, crystalline form. MAP® is indicated as a safe and effective substitute for dietary proteins. Clinical studies have shown that the use of MAP®, during physical activity, may substitute dietary proteins or protein supplements in a safer and nutritionally more efficient way to:

MAP^® is a dietary protein substitute that provides the MAP Master Amino Acid Pattern^® (U.S. Patent No. 5,132,113) a unique pattern of essential amino acids in a highly purified, free, crystalline form. After oral ingestion, MAP^® is rapidly utilized. MAP^® does not require the aid of peptidases and therefore is absorbed within 23 minutes through the first 100 cm of functional small intestine. MAP^® does not provide any fecal residue. MAP^® is amphoteric. MAP^® is supplied in tablets of 1,000 mg for oral administration. Each tablet of MAP^® contains only the active ingredient MAP^®. MAP^® contains no inactive ingredients.

COMPOSITION

MAP^® provides the MAP Master Amino Acid Pattern^® (U.S. Patent No. 5,132,113) a unique pattern of essential amino acids in a highly purified, free, crystalline form.

CLINICAL STUDIES

The results of comparative, double-blind, triple- and quintuple-crossover Net Nitrogen Utilization^® (NNU^®) clinical studies have shown that the subjects while taking MAP^®, as a dietary protein substitute, achieved a body’s 99% NNU^®. This means that 99% of MAP’s constituent amino acids followed the anabolic pathway, thus acting as a precursor of the body’s protein synthesis. By comparison, the most nutritious dietary proteins provide an average of only 32% NNU^®. Hence, MAP^® is more nutritious than dietary proteins. This has been confirmed by the fact that during the studies, each subject body’s nitrogen balance was maintained in equilibrium by taking MAP^® as a sole and total substitute of dietary proteins in a dosage of only 400 mg/kg/day (ideal weight) which provided less than 2 kcal/day ( 1 g MAP^® = 0.04 kcal). The study’s results have also shown that 1% of MAP’s constituent amino acids followed the catabolic pathway, thus releasing only 1% of nitrogen catabolites and energy. By comparison dietary proteins release an average of 68% nitrogen catabolites and energy. These facts evidence that MAP™ is safer than dietary proteins and provides the lowest amount of energy in comparison to any dietary protein.

To illustrate: when a dietary protein is digested, it releases its constituent amino acids into the small intestine where they are absorbed. Then, those amino acids can follow either the anabolic pathway or the catabolic pathway (Fig. I).

Figure I. Dietary Protein Metabolism

For educational purposes only. Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professionals. You should not use the information contained herein for diagnosing or treating a health problem or disease or prescribing any medication. If you have or suspect that you have a medical problem, promptly contact your health care provider. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Customer reviews are provided for informational purposes only. Customer reviews reflect the individual reviewer’s results and experiences only and are not verified or endorsed.